Search

Your search keyword '"Zhai, Shenyong"' showing total 12 results
Start Over Author "Zhai, Shenyong"
12 results on '"Zhai, Shenyong"'

2. Severe fever with thrombocytopenia syndrome, Shandong Province, China, 2011

Author

Wen, Hong-Ling, Zhao, Li, Zhai, Shenyong, Chi, Yuanyuan, Cui, Feng, Wang, Dongxu, Wang, Ling, Wang, Zhiyu, Wang, Qian, Zhang, Shoufeng, Liu, Yan, Yu, Hao, and Yu, Xue-Jie

Subjects
Diagnosis, Health aspects, Enzyme-linked immunosorbent assay -- Health aspects, Thrombocytopenia -- Diagnosis -- Health aspects, Infection -- Diagnosis -- Health aspects
Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that was identified in 2009 in rural areas in China. This disease is caused by SFTS virus (SFTSV), a [...]

Published
2014
Full Text
View/download PDF

3. Severe fever with thrombocytopenia syndrome virus, Shandong Province, China

Author

Zhao, Li, Zhai, Shenyong, Wen, Hongling, Cui, Feng, Chi, Yuanyuan, Wang, Ling, Xue, Fuzhong, Wang, Qian, Wang, Zhiyu, Zhang, Shoufeng, Song, Yanyan, Du, Jun, and Yu, Xue-jie

Subjects
Diagnosis, Care and treatment, Complications and side effects, Research, Risk factors, Thrombocytopenia -- Diagnosis -- Research -- Care and treatment -- Complications and side effects, Fever -- Risk factors -- Research -- Diagnosis, Hyperthermia -- Risk factors -- Research -- Diagnosis
Abstract

SFTSV is classified in the family Bunyaviridae, genus Phlebovirus, and is believed to be transmitted by ticks because the virus has been detected in Haemaphysalis longicornis ticks (1). However, the [...]

Published
2012
Full Text
View/download PDF

4. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases

Author

Pan Xiangou, Liu Tianshu, Zhai Shenyong, Ren Li, Liang Li, Wei Ye, Fan Jia, Xu Bo, Zhong Yunshi, Ye Lechi, Li Haohao, Zhu Dexiang, Qin Xinyu, Ye Qinghai, Xu Jianmin, and Wu Haifu

Subjects
Liver surgery, Adult, Male, medicine.medical_specialty, Adolescent, CA-19-9 Antigen, Organoplatinum Compounds, Oxaloacetates, Hepatic resection, Leucovorin, Kaplan-Meier Estimate, Cryosurgery, Deoxycytidine, Disease-Free Survival, Metastasis, Young Adult, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, medicine, Hepatectomy, Humans, Chemoembolization, Therapeutic, Capecitabine, Aged, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Chi-Square Distribution, business.industry, Liver Neoplasms, Middle Aged, medicine.disease, Hepatic metastasis, Surgery, Carcinoembryonic Antigen, Tumor Burden, Oncology, Chemotherapy, Adjuvant, Multivariate Analysis, Catheter Ablation, Camptothecin, Female, Fluorouracil, business, Colorectal Neoplasms, Follow-Up Studies
Abstract

This study was designed to evaluate the long-time outcome of patients with colorectal liver metastasis (CRLM) undergoing different types of therapy and identify prognosis factors.From 2000 to 2010, 1,613 consecutive patients with CRLM were identified. Clinicopathological and outcome data were collected and analyzed by univariate and multivariate analyses.Synchronous liver metastasis (SLM), female, grade III-IV, T4 and N positive of primary tumor, bilobar disease, number of liver metastases ≥ 4, size of largest liver metastases ≥ 5 cm, serum CEA level ≥ 5 ng/ml, and CA19-9 level ≥ 37 u/ml were the predictors of adverse outcome using univariate analysis. The median survival and 5-year survival rate for patients after resection of liver metastases was 49.8 months and 47%, better than that for those after other therapy. In addition, patients without treatment had the poorest survival. Sixty-four initially unresectable patients underwent surgery after conversion therapy with a median survival of 36.9 months and a 5-year survival of 30%. By multivariate analysis, SLM, poorly differentiated primary tumor, number of liver metastases ≥ 4, size of largest liver metastases ≥ 5 cm, and no surgical treatment of liver metastases were found to be independent predictors of poor survival.Patients with CRLM could get long-term survival benefit from different types of therapy, and resection of liver metastases was the optimal strategy. A predictive model using these above five factors may be of use in stratifying patients who may benefit from intensive surveillance and adjuvant therapy.

Published
2012

9. Linoleic acid and breast cancer risk: a meta-analysis.

Author

Yunping Zhou, Tao Wang, Shenyong Zhai, Wei Li, Qiang Meng, Zhou, Yunping, Wang, Tao, Zhai, Shenyong, Li, Wei, and Meng, Qiang

Subjects
BREAST cancer risk factors, LINOLEIC acid, BLOOD serum analysis, DIETARY supplements, EVIDENCE-based medicine, BREAST tumors, COMPARATIVE studies, DIET, RESEARCH methodology, MEDICAL cooperation, META-analysis, RESEARCH, EVALUATION research
Abstract

Objective: Prior studies on linoleic acid, the predominant n-6 fatty acid, and breast cancer risk have generated inconsistent results. We performed a meta-analysis to summarize the evidence regarding the relationship of dietary and serum linoleic acid with breast cancer risk.Design: Pertinent studies were identified by a search of PubMed and EMBASE. The fixed- or random-effect pooled measure was selected based on between-study heterogeneity.Results: Eight prospective cohort studies and four prospective nested case-control studies, involving 10 410 breast cancer events from 358 955 adult females across different countries, were included in present study. Compared with the lowest level of linoleic acid, the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid. The pooled RR (95 % CI) for dietary and serum linoleic acid were 0·99 (0·92, 1·06) and 0·98 (0·88, 1·08), respectively. The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively. The risk of breast cancer decreased by 1 % (RR=0·99; 95 % CI 0·93, 1·05) for every 10 g/d increment in linoleic acid intake.Conclusions: This meta-analysis indicated that both dietary linoleic acid intake and serum linoleic acid level were associated with decreased risk of breast cancer, although none of the associations were statistically significant. Further investigations are warranted. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

11. Prevalence of hemorrhagic fever with renal syndrome in Yiyuan County, China, 2005-2014.

Author

Tao Wang, Jie Liu, Yunping Zhou, Feng Cui, Zhenshui Huang, Ling Wang, Shenyong Zhai, Wang, Tao, Liu, Jie, Zhou, Yunping, Cui, Feng, Huang, Zhenshui, Wang, Ling, and Zhai, Shenyong

Subjects
HEMORRHAGIC fever with renal syndrome, DISEASE prevalence, ARBOVIRUS diseases, TREATMENT effectiveness, BOX-Jenkins forecasting, EPIDEMICS, HANTAVIRUSES, SEASONS, DISEASE incidence
Abstract

Background: Hemorrhagic fever with renal syndrome (HFRS) is highly endemic in mainland China, where human cases account for 90 % of the total global cases. Yiyuan County is one of the most serious affected areas in China. Therefore, there is an urgent need for monitoring and predicting HFRS incidence in Yiyuan to make the control of HFRS more effective.Methods: The study was based on the reported cases of HFRS from the National Notifiable Disease Surveillance System. The demographic and spatial distributions of HFRS in Yiyuan were established. Then we fit autoregressive integrated moving average (ARIMA) models and predict the HFRS epidemic trend.Results: There were 362 cases reported in Yiyuan during the 10-year study period. The human infections in the fall and winter reflected a seasonal characteristic pattern of Hantaan virus (HTNV) transmission. The best model was ARIMA (2, 1, 1) × (0, 1, 1)12 (AIC value 516.86) with a high validity.Conclusion: The ARIMA model fits the fluctuations in HFRS frequency and it can be used for future forecasting when applied to HFRS prevention and control. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results